These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 26802628)
1. Systematic substrate identification indicates a central role for the metalloprotease ADAM10 in axon targeting and synapse function. Kuhn PH; Colombo AV; Schusser B; Dreymueller D; Wetzel S; Schepers U; Herber J; Ludwig A; Kremmer E; Montag D; Müller U; Schweizer M; Saftig P; Bräse S; Lichtenthaler SF Elife; 2016 Jan; 5():. PubMed ID: 26802628 [TBL] [Abstract][Full Text] [Related]
2. The alpha secretase ADAM10: A metalloprotease with multiple functions in the brain. Saftig P; Lichtenthaler SF Prog Neurobiol; 2015 Dec; 135():1-20. PubMed ID: 26522965 [TBL] [Abstract][Full Text] [Related]
3. A disintegrin and metalloprotease 10 (ADAM10) is a central regulator of murine liver tissue homeostasis. Müller M; Wetzel S; Köhn-Gaone J; Chalupsky K; Lüllmann-Rauch R; Barikbin R; Bergmann J; Wöhner B; Zbodakova O; Leuschner I; Martin G; Tiegs G; Rose-John S; Sedlacek R; Tirnitz-Parker JE; Saftig P; Schmidt-Arras D Oncotarget; 2016 Apr; 7(14):17431-41. PubMed ID: 26942887 [TBL] [Abstract][Full Text] [Related]
4. NrCAM is a marker for substrate-selective activation of ADAM10 in Alzheimer's disease. Brummer T; Müller SA; Pan-Montojo F; Yoshida F; Fellgiebel A; Tomita T; Endres K; Lichtenthaler SF EMBO Mol Med; 2019 Apr; 11(4):. PubMed ID: 30833305 [TBL] [Abstract][Full Text] [Related]
5. The Gut-Brain Axis in Autism Spectrum Disorder: A Focus on the Metalloproteases ADAM10 and ADAM17. Zheng Y; Verhoeff TA; Perez Pardo P; Garssen J; Kraneveld AD Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374371 [TBL] [Abstract][Full Text] [Related]
6. Regulation of the trafficking and the function of the metalloprotease ADAM10 by tetraspanins. Saint-Pol J; Eschenbrenner E; Dornier E; Boucheix C; Charrin S; Rubinstein E Biochem Soc Trans; 2017 Aug; 45(4):937-44. PubMed ID: 28687716 [TBL] [Abstract][Full Text] [Related]
7. Human and Murine Interleukin 23 Receptors Are Novel Substrates for A Disintegrin and Metalloproteases ADAM10 and ADAM17. Franke M; Schröder J; Monhasery N; Ackfeld T; Hummel TM; Rabe B; Garbers C; Becker-Pauly C; Floss DM; Scheller J J Biol Chem; 2016 May; 291(20):10551-61. PubMed ID: 26961870 [TBL] [Abstract][Full Text] [Related]
8. L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth. Maretzky T; Schulte M; Ludwig A; Rose-John S; Blobel C; Hartmann D; Altevogt P; Saftig P; Reiss K Mol Cell Biol; 2005 Oct; 25(20):9040-53. PubMed ID: 16199880 [TBL] [Abstract][Full Text] [Related]
9. Postnatal disruption of the disintegrin/metalloproteinase ADAM10 in brain causes epileptic seizures, learning deficits, altered spine morphology, and defective synaptic functions. Prox J; Bernreuther C; Altmeppen H; Grendel J; Glatzel M; D'Hooge R; Stroobants S; Ahmed T; Balschun D; Willem M; Lammich S; Isbrandt D; Schweizer M; Horré K; De Strooper B; Saftig P J Neurosci; 2013 Aug; 33(32):12915-28, 12928a. PubMed ID: 23926248 [TBL] [Abstract][Full Text] [Related]
10. Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress. Clement AB; Hanstein R; Schröder A; Nagel H; Endres K; Fahrenholz F; Behl C Neuroscience; 2008 Mar; 152(2):459-68. PubMed ID: 18276079 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding. Shackleton B; Crawford F; Bachmeier C Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326 [TBL] [Abstract][Full Text] [Related]
13. ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker. Manzine PR; Ettcheto M; Cano A; Busquets O; Marcello E; Pelucchi S; Di Luca M; Endres K; Olloquequi J; Camins A; Cominetti MR Biomed Pharmacother; 2019 May; 113():108661. PubMed ID: 30836275 [TBL] [Abstract][Full Text] [Related]
14. LC-MS based cleavage site profiling of the proteases ADAM10 and ADAM17 using proteome-derived peptide libraries. Tucher J; Linke D; Koudelka T; Cassidy L; Tredup C; Wichert R; Pietrzik C; Becker-Pauly C; Tholey A J Proteome Res; 2014 Apr; 13(4):2205-14. PubMed ID: 24635658 [TBL] [Abstract][Full Text] [Related]
15. The Role of ADAM10 in Alzheimer's Disease. Yuan XZ; Sun S; Tan CC; Yu JT; Tan L J Alzheimers Dis; 2017; 58(2):303-322. PubMed ID: 28409746 [TBL] [Abstract][Full Text] [Related]
16. Neuronal ADAM10 Promotes Outgrowth of Small-Caliber Myelinated Axons in the Peripheral Nervous System. Meyer zu Horste G; Derksen A; Stassart R; Szepanowski F; Thanos M; Stettner M; Boettcher C; Lehmann HC; Hartung HP; Kieseier BC J Neuropathol Exp Neurol; 2015 Nov; 74(11):1077-85. PubMed ID: 26426268 [TBL] [Abstract][Full Text] [Related]
17. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP. Corbett GT; Gonzalez FJ; Pahan K Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426 [TBL] [Abstract][Full Text] [Related]
18. Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease. Schroeder A; Fahrenholz F; Schmitt U J Alzheimers Dis; 2009; 16(2):309-14. PubMed ID: 19221420 [TBL] [Abstract][Full Text] [Related]
19. GPR37 is processed in the N-terminal ectodomain by ADAM10 and furin. Mattila SO; Tuhkanen HE; Lackman JJ; Konzack A; Morató X; Argerich J; Saftig P; Ciruela F; Petäjä-Repo UE FASEB J; 2021 Jun; 35(6):e21654. PubMed ID: 34042202 [TBL] [Abstract][Full Text] [Related]
20. Endoglycan (PODXL2) is proteolytically processed by ADAM10 (a disintegrin and metalloprotease 10) and controls neurite branching in primary neurons. Hsia HE; Tüshaus J; Feng X; Hofmann LI; Wefers B; Marciano DK; Wurst W; Lichtenthaler SF FASEB J; 2021 Sep; 35(9):e21813. PubMed ID: 34390512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]